News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
868,682 Results
Type
Article (87847)
Company Profile (743)
Press Release (780073)
Multimedia
Podcasts (197)
Webinars (28)
Section
Business (233222)
Career Advice (4144)
Deals (39883)
Drug Delivery (150)
Drug Development (91362)
Employer Resources (205)
FDA (18356)
Job Trends (17428)
News (397756)
Policy (39942)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3011)
Academic (1)
Accelerated approval (34)
Adcomms (32)
Allergies (145)
Alliances (56969)
ALS (180)
Alzheimer's disease (1788)
Antibody-drug conjugate (ADC) (342)
Approvals (18558)
Artificial intelligence (579)
Autoimmune disease (160)
Automation (38)
Bankruptcy (404)
Best Places to Work (12617)
BIOSECURE Act (23)
Biosimilars (204)
Biotechnology (458)
Bladder cancer (161)
Brain cancer (62)
Breast cancer (658)
Cancer (4996)
Cardiovascular disease (439)
Career advice (3570)
Career pathing (41)
CAR-T (302)
CDC (54)
Celiac Disease (2)
Cell therapy (811)
Cervical cancer (37)
Clinical research (76967)
Collaboration (1819)
Company closure (4)
Compensation (1165)
Complete response letters (69)
COVID-19 (2986)
CRISPR (99)
C-suite (863)
Cystic fibrosis (153)
Data (6305)
Decentralized trials (2)
Denatured (73)
Depression (144)
Diabetes (511)
Diagnostics (7218)
Digital health (45)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (274)
Drug pricing (211)
Drug shortages (32)
Duchenne muscular dystrophy (238)
Earnings (100057)
Editorial (63)
Employer branding (25)
Employer resources (173)
Events (134905)
Executive appointments (1004)
FDA (21517)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1535)
Gene editing (216)
Generative AI (52)
Gene therapy (665)
GLP-1 (1098)
Government (5421)
Grass and pollen (7)
Guidances (385)
Healthcare (20920)
HIV (58)
Huntington's disease (50)
IgA nephropathy (85)
Immunology and inflammation (287)
Immuno-oncology (62)
Indications (104)
Infectious disease (3259)
Inflammatory bowel disease (205)
Inflation Reduction Act (17)
Influenza (117)
Intellectual property (249)
Interviews (816)
IPO (17954)
IRA (57)
Job creations (5200)
Job search strategy (2866)
JPM (69)
Kidney cancer (16)
Labor market (94)
Layoffs (653)
Leadership (39)
Legal (10147)
Liver cancer (98)
Longevity (15)
Lung cancer (672)
Lymphoma (381)
Machine learning (44)
Management (66)
Manufacturing (838)
MASH (174)
Medical device (14988)
Medtech (15040)
Mergers & acquisitions (22972)
Metabolic disorders (1362)
Multiple sclerosis (161)
NASH (23)
Neurodegenerative disease (349)
Neuropsychiatric disorders (97)
Neuroscience (3092)
Neurotech (1)
NextGen: Class of 2026 (7688)
Non-profit (5107)
Now hiring (66)
Obesity (655)
Opinion (332)
Ovarian cancer (169)
Pain (208)
Pancreatic cancer (232)
Parkinson's disease (293)
Partnered (37)
Patents (504)
Patient recruitment (490)
Peanut (60)
People (66843)
Pharmaceutical (135)
Pharmacy benefit managers (32)
Phase 1 (23792)
Phase 2 (33415)
Phase 3 (25165)
Pipeline (5193)
Policy (332)
Postmarket research (3553)
Preclinical (10681)
Press Release (72)
Prostate cancer (243)
Psychedelics (55)
Radiopharmaceuticals (299)
Rare diseases (908)
Real estate (7439)
Recruiting (80)
Regulatory (28992)
Reports (67)
Research institute (2721)
Resumes & cover letters (651)
Rett syndrome (28)
RNA editing (21)
RSV (78)
Schizophrenia (157)
Series A (260)
Series B (197)
Service/supplier (27)
Sickle cell disease (104)
Special edition (27)
Spinal muscular atrophy (177)
Sponsored (48)
Startups (4334)
State (2)
Stomach cancer (18)
Supply chain (107)
Tariffs (95)
The Weekly (122)
Vaccines (1127)
Venture capital (97)
Weight loss (442)
Women's health (92)
Worklife (22)
Date
Last 7 days (624)
Last 30 days (2208)
Last 365 days (31368)
2026 (2976)
2025 (31829)
2024 (37559)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1289)
Alabama (92)
Alaska (7)
Arizona (339)
Arkansas (14)
Asia (51535)
Australia (9053)
California (11535)
Canada (3305)
China (1166)
Colorado (489)
Connecticut (486)
Delaware (341)
Europe (118259)
Florida (1694)
Georgia (364)
Hawaii (4)
Idaho (68)
Illinois (926)
India (68)
Indiana (530)
Iowa (24)
Japan (429)
Kansas (133)
Kentucky (41)
Louisiana (29)
Maine (77)
Maryland (1445)
Massachusetts (8440)
Michigan (336)
Minnesota (651)
Mississippi (6)
Missouri (129)
Montana (34)
Nebraska (29)
Nevada (125)
New Hampshire (82)
New Jersey (3071)
New Mexico (32)
New York (3044)
North Carolina (1597)
North Dakota (10)
Northern California (5560)
Ohio (338)
Oklahoma (23)
Oregon (53)
Pennsylvania (2305)
Puerto Rico (23)
Rhode Island (49)
South America (1663)
South Carolina (65)
South Dakota (1)
Southern California (4444)
Tennessee (174)
Texas (1791)
United States (41306)
Utah (345)
Vermont (1)
Virginia (274)
Washington D.C. (85)
Washington State (968)
West Virginia (4)
Wisconsin (114)
Wyoming (2)
868,682 Results for "kronos bio inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ignota Labs Acquires Kronos’s Clinical Pipeline
October 6, 2025
·
2 min read
Biotech Bay
Kronos Bio to Participate in Three Upcoming Healthcare Conferences and Events
Kronos Bio, Inc. today announced that the company would participate in three upcoming healthcare conferences and events.
May 22, 2024
·
1 min read
Mergers & acquisitions
Kronos Accepts $35M Concentra Buyout as Walls Close In
After multiple rounds of layoffs that cut Kronos down to just 10 people, the small molecule biotech has accepted a buyout offer from Kevin Tang’s Concentra Biosciences.
May 2, 2025
·
2 min read
·
Annalee Armstrong
Business
Kronos Bio Reports First-Quarter 2024 Financial Results
Kronos Bio, Inc. reported recent business progress and financial results for the first-quarter of 2024.
May 9, 2024
·
7 min read
Press Releases
ABS Bio, Inc. acquires Cureline, Inc. to strengthen support of biopharma drug discovery
January 7, 2026
·
1 min read
Press Releases
Zydus Lifesciences Limited completes the acquisition of Agenus Inc.'s biologics manufacturing facilities, launches Zylidac Bio LLC in the U.S.
January 16, 2026
·
3 min read
Business
Kronos Bio Implements New Leadership Structure to Drive Pipeline Advancement
Kronos Bio, Inc., a company dedicated to transforming the lives of those affected by cancer, announced a streamlined leadership structure designed to focus on pipeline advancement and align with Kronos Bio’s current operating needs.
January 25, 2024
·
6 min read
Business
Kronos Bio Appoints Deborah Knobelman, Ph.D. as Chief Operating Officer and Chief Financial Officer
Kronos Bio, Inc. today announced that it has appointed Deborah Knobelman, Ph.D., as Chief Operating Officer and Chief Financial Officer effective June 3, 2024.
May 21, 2024
·
3 min read
Press Releases
Kronos Bio Reports Fourth Quarter and Full Year 2024 Financial Results
March 18, 2025
·
3 min read
Press Releases
Kronos Bio Enters into Agreement to Be Acquired by Concentra Biosciences for $0.57 in Cash per Share Plus a Contingent Value Right
May 1, 2025
·
6 min read
1 of 86,869
Next
